Search Results - "Luchs, J I"

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    Keratitis, ulceration, and perforation associated with topical nonsteroidal anti-inflammatory drugs by Guidera, A C, Luchs, J I, Udell, I J

    Published in Ophthalmology (Rochester, Minn.) (01-05-2001)
    “…To report corneal complications associated with topical nonsteroidal anti-inflammatory drugs (NSAIDs). Retrospective, noncomparative interventional case…”
    Get more information
    Journal Article
  2. 2

    Ulcerative keratitis in bullous keratopathy by Luchs, J I, Cohen, E J, Rapuano, C J, Laibson, P R

    Published in Ophthalmology (Rochester, Minn.) (01-05-1997)
    “…The authors review a large series of patients with bullous keratopathy (BK) to analyze the frequency of ulcerative keratitis, and determine the contributory…”
    Get more information
    Journal Article
  3. 3

    Comparison of keratometric values of healthy and diseased eyes measured by Javal keratometer, EyeSys, and PAR by Varssano, D, Rapuano, C J, Luchs, J I

    Published in Journal of cataract and refractive surgery (01-04-1997)
    “…To compare the simulated keratometric results of the PAR CTS and the EyeSys corneal imaging systems with Javal keratometer readings in keratoconus eyes, in…”
    Get more information
    Journal Article
  4. 4
  5. 5

    A Phase II/III, randomized, double-masked, vehicle-controlled, dose-ranging study of the safety and efficacy of OTX-101 in the treatment of dry eye disease by Tauber, Joseph, Schechter, Barry A, Bacharach, Jason, Toyos, Melissa M, Smyth-Medina, Robert, Weiss, Sidney L, Luchs, Jodi I

    Published in Clinical ophthalmology (Auckland, N.Z.) (01-01-2018)
    “…The aim of this study was to evaluate the safety and efficacy of OTX-101, a clear nanomicellar aqueous solution of cyclosporine, in the treatment of dry eye…”
    Get full text
    Journal Article
  6. 6

    Effect of OTX-101 in Patients with Dry Eye Disease at Day 14 of Treatment: Ocular Surface Endpoint Results from the Phase 2b/3 Clinical Trial by Schechter, Barry A, Urbieta, Maitee, Bacharach, Jason, Toyos, Melissa, Smyth-Medina, Robert, Mitchell, Brittany, Luchs, Jodi I

    Published in Clinical ophthalmology (Auckland, N.Z.) (01-01-2022)
    “…Dry eye disease (DED) is a multifactorial disorder characterized by loss of tear film homeostasis, which initiates a cycle of ocular surface inflammation and…”
    Get full text
    Journal Article
  7. 7

    Infantile ulcerative keratitis secondary to congenital entropion by Luchs, J I, Laibson, P R, Stefanyszyn, M A, Rapuano, C J, Cohen, E J, Schnall, B M, Raber, I M

    Published in Cornea (01-01-1997)
    “…Congenital entropion is a rare eyelid anomaly that can cause chronic corneal erosions or ulceration. The diagnosis may be easily overlooked by both the…”
    Get more information
    Journal Article
  8. 8

    Safety and efficacy of amniotic cytokine extract in the treatment of dry eye disease by Yeu, Elizabeth, Goldberg, Damien F, Mah, Francis S, Beckman, Kenneth A, Luchs, Jodi I, Solomon, Jonathan D, White, Darrell E, Gupta, Preeya K

    Published in Clinical ophthalmology (Auckland, N.Z.) (01-05-2019)
    “…Evaluate the safety and efficacy of cryopreserved amniotic cytokine extract (ACE) in the treatment of subjects with dry eye disease (DED). This was a…”
    Get full text
    Journal Article
  9. 9

    A Phase II/III, randomized, double-masked, vehicle-controlled, dose-ranging study of the safety and efficacy of OTX-101 in the treatment of dry eye disease [Corrigendum] by Tauber, Joseph, Schechter, Barry A, Bacharach, Jason, Toyos, Melissa M, Smyth-Medina, Robert, Weiss, Sidney L, Luchs, Jodi I

    Published in Clinical ophthalmology (Auckland, N.Z.) (01-01-2019)
    “…Tauber J, Schechter BA, Bacharach J, et al. Clin Ophthalmol.2018;12:1921-1929.On page 1927, "Safety and tolerability assessments" section,third paragraph,…”
    Get full text
    Journal Article
  10. 10

    A Phase II /III, randomized, double-masked, vehicle-controlled, dose-ranging study of the safety and efficacy of OTX-101 in the treatment of dry eye disease [Corrigendum] by Tauber, Joseph, Schechter, Barry A, Bacharach, Jason, Toyos, Melissa M, Smyth-Medina, Robert, Weiss, Sidney L, Luchs, Jodi I

    Published in Clinical ophthalmology (Auckland, N.Z.) (01-01-2018)
    “…Tauber J, Schechter BA, Bacharach J, et al. Clin Ophthalmol. 2018;12:1921-1929.On page 1924, Efficacy end points, Conjunctival staining section, the sentence…”
    Get full text
    Journal Article